Hello everyone. I hope I am not out of line here. I am a pharmacist looking to get out of pharmacy (long story).
I am looking to invest into a franchise health/fitness consultant company.
One of their product is a screening platform geared towards providers.
From what I understand, these are screenings that can be done on paper; however, since they have developed an electronic format they are claiming providers are able to get higher reimbursement from insurance (medicare, tricare and private insurance). Tablets would be provided to the offices to screen their patients.
Their claim is that this is a more streamlined process and would save providers time, In addition it can generate higher revenue because of their software.
The reason I am asking in a pain management forum.
Besides your general anxiety and depression screens, they have the opiod risk test and cognitive test that should be used in pain management patients.
Their reasoning is that most pain management patients would have some type of anxiety/depression/or mental illness that may not be diagnosed. And on top of that, the offices would able to show the DEA that they are cautiously screening patients if it was to ever come to that.
My role if I choose to accept would be to introduce this programs to various offices.
I would like to ask,
How likely are pain management doctor to use such a program, and is there any basis to what they are claiming with regards to the DEA?
They are claiming that doing 4 screens per day could increase a clinic's income by $20,000-$30,000.
Another product they offer is a
Epidermal Nerve Fiber Density Biopsy programs to definitively diagnosed Small fiber neuropathy. Does pain management see alot of neuropathy patients? Are there any doctors out there currently doing this type of biopsy in their practice?
Would these programs be something that is an easy sale?
I don't want to invest into something that is unproven.
thanks
I am looking to invest into a franchise health/fitness consultant company.
One of their product is a screening platform geared towards providers.
From what I understand, these are screenings that can be done on paper; however, since they have developed an electronic format they are claiming providers are able to get higher reimbursement from insurance (medicare, tricare and private insurance). Tablets would be provided to the offices to screen their patients.
Their claim is that this is a more streamlined process and would save providers time, In addition it can generate higher revenue because of their software.
The reason I am asking in a pain management forum.
Besides your general anxiety and depression screens, they have the opiod risk test and cognitive test that should be used in pain management patients.
Their reasoning is that most pain management patients would have some type of anxiety/depression/or mental illness that may not be diagnosed. And on top of that, the offices would able to show the DEA that they are cautiously screening patients if it was to ever come to that.
My role if I choose to accept would be to introduce this programs to various offices.
I would like to ask,
How likely are pain management doctor to use such a program, and is there any basis to what they are claiming with regards to the DEA?
They are claiming that doing 4 screens per day could increase a clinic's income by $20,000-$30,000.
Another product they offer is a
Epidermal Nerve Fiber Density Biopsy programs to definitively diagnosed Small fiber neuropathy. Does pain management see alot of neuropathy patients? Are there any doctors out there currently doing this type of biopsy in their practice?
Would these programs be something that is an easy sale?
I don't want to invest into something that is unproven.
thanks